Clinical Trial Update: Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial update on pegylated interferon and ribavirin in hepatitis C patients receiving opioid pharmacotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Melbourne Health | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED